Deferasirox in patients with myelodysplastic syndrome and iron overload - Results of the EPIC study - Commenting on the study

Abstract

Study of Gattermann et al. is the largest prospective study evaluating the effect of deferasirox in patients with iron overload who are transfusion-dependent at different basic diagnoses including MDS.

Keywords

• Deferasirox
• myelodysplastic syndrome
• MDS
• iron
• overload
• EPIC